Glenview Capital Management Q3 13F Filing: Increases Meta and Teva Positions
Glenview Capital Management has updated its portfolio holdings for the third quarter, revealing significant shifts in its investment strategy. The hedge fund increased its stakes in major technology and pharmaceutical players, specifically boosting positions in Meta Platforms (META) and Teva Pharmaceutical Industries (TEVA). Conversely, the fund reduced its exposure to consumer-facing and fintech sectors by cutting holdings in CVS Health (CVS) and Block (SQ). Additionally, Glenview exited its positions in Dick's Sporting Goods (DKS) and STMicroelectronics (STM), signaling a rotation away from certain retail and semiconductor names.

Topics: equity holdings fund disclosure institutional ownership